raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:99971

Well-differentiated liposarcoma

Synonyms: ALT · Atypical lipoma · Atypical lipomatous tumor · WDLS

Type
Histopathological subtype
Group
Subtype of disorder
Inheritance
Not applicable
Age of onset
Adult
Status
active

Well-differentiated liposarcoma (WDLS), the most common type of liposarcoma (LS), is a slow growing, painless tumor usually located in the retroperitoneum or the limbs. It is composed of proliferating mature adipocytes.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enWell-differentiated liposarcomaALT · Atypical lipoma · Atypical lipomatous tumor · WDLS
frLiposarcome bien différenciéALT · Lipome atypique · Tumeur lipomateuse atypique · WDLS
deLiposarkom, hochdifferenziertesALT · Lipom, atypisches · Tumor, atypischer lipomatöser · WDLS
esLiposarcoma bien diferenciadoALT · Lipoma atípico · Tumor lipomatoso atípico · WDLS
itLiposarcoma ben differenziatoALT · Lipoma atipico · Tumore lipomatoso atipico · WDLS
nlGoed gedifferentieerd liposarcoomALT · Atypisch lipoom · Atypische lipomateuze tumor · WDLS
ptLipossarcoma bem diferenciado
plTłuszczakomięsak dobrze zróżnicowanyALT · Atypowy guz tłuszczowy · Tłuszczak atypowy · WDLS
csDobře diferencovaný liposarkomALT · Atypický lipom · Atypický lipomatózní nádor · WDLS
ukДобре диференційована ліпосаркомаALT · Атипова ліпома · Атипова ліпоматозна пухлина · WDLS
zh高分化脂肪肉瘤非典型脂肪性肿瘤
trİyi diferansiye liposarkomALT · WDLS · Atipik lipom · Atipik lipomatöz tümör

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10C49.9NTBTindexvalidated
MONDO0005103Evalidated
UMLSC1370889Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

3 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CDK4Role in the phenotype ofAssessedHGNC:1773ENSG0000013544612382912q14.1cyclin dependent kinase 4
HMGA2Role in the phenotype ofAssessedHGNC:5009ENSG0000014994860069812q14.3high mobility group AT-hook 2
MDM2Role in the phenotype ofAssessedHGNC:6973ENSG0000013567916478512q15MDM2 proto-oncogene
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Annual incidence1-9 / 1 000 0000.51 / 100 000EuropeValue and classValidated22517534[PMID]_[EXPERT]
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

3 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0001482Subcutaneous nodule
Occasional (29-5%)
HP:0012211Abnormal renal physiology
HP:0002579Gastrointestinal dysmotility

Run the differential on the 1 obligate / very frequent terms

7

Sources for this card